{"id":452,"date":"2026-08-27T10:31:11","date_gmt":"2026-08-27T10:31:11","guid":{"rendered":"https:\/\/nhdbio.com\/cagrilintide-vs-cagrisema-evidence-boundaries\/"},"modified":"2026-08-28T07:31:46","modified_gmt":"2026-08-28T07:31:46","slug":"cagrilintide-vs-cagrisema-evidence-boundaries","status":"publish","type":"post","link":"https:\/\/nhdbio.com\/fr\/cagrilintide-vs-cagrisema-evidence-boundaries\/","title":{"rendered":"Cagrilintide vs CagriSema\u00a0: mol\u00e9cules, preuves d'essais et confusions courantes"},"content":{"rendered":"<p class=\"pim-standfirst wp-block-paragraph\">Cagrilintide, s\u00e9maglutide et CagriSema sont des termes apparent\u00e9s, mais ils ne d\u00e9crivent pas la m\u00eame intervention. Les pages de recherche fusionnent souvent leurs preuves, ce qui cr\u00e9e des erreurs factuelles et peut impliquer une \u00e9quivalence que l'\u00e9tude cit\u00e9e n'a jamais test\u00e9e.<\/p><div class=\"wp-block-group pim-key-takeaways\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\"><h2 class=\"wp-block-heading\">Points cl\u00e9s \u00e0 retenir<\/h2><ul class=\"wp-block-list\"><li>Cagrilintide active les voies des r\u00e9cepteurs de l'amyline\u00a0; le s\u00e9maglutide active le r\u00e9cepteur GLP-1.<\/li><li>Les essais CagriSema ont \u00e9tudi\u00e9 la co-administration sp\u00e9cifi\u00e9e des deux composants, et non tous les m\u00e9langes ou ratios possibles.<\/li><li>Les r\u00e9sultats combin\u00e9s appartiennent \u00e0 l'intervention d'essai et \u00e0 la population\u00a0; ce ne sont pas des promesses de produits g\u00e9n\u00e9riques.<\/li><\/ul><\/div><\/div><figure class=\"wp-block-image size-full pim-article-figure\"><img loading=\"lazy\" decoding=\"async\" width=\"1672\" height=\"941\" src=\"http:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/metabolic-peptide-receptor-research.png\" alt=\"Chercheur examinant trois voies de signalisation des r\u00e9cepteurs peptidiques dans un laboratoire de biologie mol\u00e9culaire\" class=\"wp-image-442\" srcset=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/metabolic-peptide-receptor-research.png 1672w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/metabolic-peptide-receptor-research-300x169.png 300w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/metabolic-peptide-receptor-research-1024x576.png 1024w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/metabolic-peptide-receptor-research-768x432.png 768w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/metabolic-peptide-receptor-research-1536x864.png 1536w\" sizes=\"auto, (max-width: 1672px) 100vw, 1672px\" \/><figcaption class=\"wp-element-caption\">Illustration conceptuelle de voies de r\u00e9cepteurs distinctes\u00a0; il ne repr\u00e9sente pas un m\u00e9lange commercial ou un r\u00e9sultat clinique.<\/figcaption><\/figure><h2 class=\"wp-block-heading\">Trois termes, trois objets de preuve<\/h2><p class=\"wp-block-paragraph\">Cagrilintide est un analogue de l'amyline \u00e0 action prolong\u00e9e. Le s\u00e9maglutide est un agoniste des r\u00e9cepteurs GLP-1 et l'ingr\u00e9dient actif de m\u00e9dicaments sp\u00e9cifiques approuv\u00e9s. CagriSema est le nom utilis\u00e9 pour leur co-administration dans des programmes de d\u00e9veloppement particuliers. Le fait que deux composants apparaissent ensemble n\u2019efface pas leurs identit\u00e9s distinctes ni leurs exigences de qualit\u00e9.<\/p><div class=\"wp-block-group pim-evidence-table\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\"><div class=\"pim-evidence-row\"><strong>Cagrilintide<\/strong><span>Analogue d'amyline\u00a0; preuves de d\u00e9veloppement d'un agent unique<\/span><\/div><div class=\"pim-evidence-row\"><strong>S\u00e9maglutide<\/strong><span>agoniste des r\u00e9cepteurs GLP-1\u00a0; il existe des utilisations approuv\u00e9es sp\u00e9cifiques au produit<\/span><\/div><div class=\"pim-evidence-row\"><strong>CagriSema<\/strong><span>Co-administration clinique sp\u00e9cifi\u00e9e de cagrilintide et de s\u00e9maglutide<\/span><\/div><\/div><\/div><h2 class=\"wp-block-heading\">Ce que les documents 3 de la nouvelle phase ajoutent<\/h2><p class=\"wp-block-paragraph\">Les \u00e9tudes de phase 3a publi\u00e9es dans 2025 ont \u00e9valu\u00e9 le cagrilintide-semaglutide chez des adultes en surpoids ou ob\u00e8ses, y compris des populations atteintes de diab\u00e8te de type 2. Dans 2026, REIMAGINE 2 a rapport\u00e9 une comparaison directe incluant des groupes combin\u00e9s et \u00e0 un seul composant pour les r\u00e9sultats glyc\u00e9miques dans le diab\u00e8te de type 2.<\/p><p class=\"wp-block-paragraph\">Ces enregistrements sont pr\u00e9cieux car leur conception pr\u00e9cise les composants, le produit d'essai, la population et les param\u00e8tres. Ils ne doivent pas \u00eatre raccourcis en \u00ab \u0153uvres cagrilintides comme CagriSema \u00bb ou utilis\u00e9s pour valider un m\u00e9lange de catalogue sans rapport.<\/p><h2 class=\"wp-block-heading\">Comment une page mixte doit citer la litt\u00e9rature<\/h2><p class=\"wp-block-paragraph\">Une page de m\u00e9lange responsable doit relier les enregistrements d'identit\u00e9 d'un seul composant, indiquer le ratio de catalogue r\u00e9el et les contr\u00f4les analytiques, et citer les essais de combinaison comme contexte de recherche externe. Il doit \u00e9galement indiquer que l'intervention publi\u00e9e n'\u00e9tablit pas la qualit\u00e9, la s\u00e9curit\u00e9 ou l'efficacit\u00e9 du lot du catalogue fourni.<\/p>","protected":false},"excerpt":{"rendered":"<p>Une comparaison claire du cagrilintide, du s\u00e9maglutide et de la combinaison CagriSema \u00e9tudi\u00e9e, y compris les enregistrements 3 de la phase 2025 \u2013 2026 et les limites du transfert de preuves.<\/p>","protected":false},"author":1,"featured_media":622,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"pim_family_ids":"320,321","pim_article_type":"Comparative evidence explainer","pim_evidence_level":"Phase 2 single-agent and phase 3 combination evidence","pim_reviewer":"NHD evidence editorial workflow","pim_reviewed_date":"2026-08-27","pim_editorial_note":"Source-checked against the linked primary or authoritative records on 2026-08-27. This is an evidence summary, not independent peer review, medical advice or validation of a catalog lot.","pim_review_status":"reviewed","pim_review_reason":"At least two linked primary or authoritative records and an explicit evidence boundary are present.","pim_creation_method":"The editorial workflow starts with linked peer-reviewed papers, trial registries or regulatory records; extracts the population or model, endpoints, numerical results and limitations; and separates the studied intervention from catalog material. AI-assisted drafting was used to structure the first version. Claims, figures, evidence labels and limitations were checked against the linked records in the site editorial workflow. This is not independent peer review.","pim_sources":"[{\"title\":\"Cagrilintide phase 2 single-agent trial\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34798060\/\",\"note\":\"Single-agent evidence.\"},{\"title\":\"CagriSema in adults with overweight or obesity and type 2 diabetes\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40544432\/\",\"note\":\"Phase 3a combination trial; PMID 40544432.\"},{\"title\":\"REIMAGINE 2 cagrilintide-semaglutide comparative phase 3 study\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/42251859\/\",\"note\":\"2026 comparative trial; PMID 42251859.\"}]","footnotes":""},"categories":[18],"tags":[],"class_list":["post-452","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-evidence-reviews"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.0 (Yoast SEO v28.1) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Cagrilintide vs CagriSema: Molecules, Trial Evidence and Common Mix-Ups - NHD<\/title>\n<meta name=\"description\" content=\"A clean comparison of cagrilintide, semaglutide and the studied CagriSema combination, including 2025\u20132026 phase 3 records and limits on transferring evidence.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nhdbio.com\/fr\/cagrilintide-vs-cagrisema-evidence-boundaries\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cagrilintide vs CagriSema: Molecules, Trial Evidence and Common Mix-Ups\" \/>\n<meta property=\"og:description\" content=\"A clean comparison of cagrilintide, semaglutide and the studied CagriSema combination, including 2025\u20132026 phase 3 records and limits on transferring evidence.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nhdbio.com\/fr\/cagrilintide-vs-cagrisema-evidence-boundaries\/\" \/>\n<meta property=\"og:site_name\" content=\"NHD\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-27T10:31:11+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-28T07:31:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/cagrilintide-vs-cagrisema-evidence-boundaries-featured-v2.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1536\" \/>\n\t<meta property=\"og:image:height\" content=\"960\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"NHD Technical Team\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Peptide Raw Materials and Custom Peptide Synthesis\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"NHD Technical Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/cagrilintide-vs-cagrisema-evidence-boundaries\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/cagrilintide-vs-cagrisema-evidence-boundaries\\\/\"},\"author\":{\"name\":\"NHD Technical Team\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\"},\"headline\":\"Cagrilintide vs CagriSema: Molecules, Trial Evidence and Common Mix-Ups\",\"datePublished\":\"2026-08-27T10:31:11+00:00\",\"dateModified\":\"2026-08-28T07:31:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/cagrilintide-vs-cagrisema-evidence-boundaries\\\/\"},\"wordCount\":306,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/cagrilintide-vs-cagrisema-evidence-boundaries\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/cagrilintide-vs-cagrisema-evidence-boundaries-featured-v2.webp\",\"articleSection\":[\"Evidence Reviews\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/cagrilintide-vs-cagrisema-evidence-boundaries\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/cagrilintide-vs-cagrisema-evidence-boundaries\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/cagrilintide-vs-cagrisema-evidence-boundaries\\\/\",\"name\":\"Cagrilintide vs CagriSema: Molecules, Trial Evidence and Common Mix-Ups - NHD\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/cagrilintide-vs-cagrisema-evidence-boundaries\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/cagrilintide-vs-cagrisema-evidence-boundaries\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/cagrilintide-vs-cagrisema-evidence-boundaries-featured-v2.webp\",\"datePublished\":\"2026-08-27T10:31:11+00:00\",\"dateModified\":\"2026-08-28T07:31:46+00:00\",\"description\":\"A clean comparison of cagrilintide, semaglutide and the studied CagriSema combination, including 2025\u20132026 phase 3 records and limits on transferring evidence.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/cagrilintide-vs-cagrisema-evidence-boundaries\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/cagrilintide-vs-cagrisema-evidence-boundaries\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/cagrilintide-vs-cagrisema-evidence-boundaries\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/cagrilintide-vs-cagrisema-evidence-boundaries-featured-v2.webp\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/cagrilintide-vs-cagrisema-evidence-boundaries-featured-v2.webp\",\"width\":1536,\"height\":960,\"caption\":\"Article-specific editorial image.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/cagrilintide-vs-cagrisema-evidence-boundaries\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nhdbio.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cagrilintide vs CagriSema: Molecules, Trial Evidence and Common Mix-Ups\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"name\":\"NHD\",\"description\":\"Peptide Raw Materials and Custom Peptide Synthesis\",\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nhdbio.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\",\"name\":\"NHD\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"width\":2172,\"height\":724,\"caption\":\"NHD\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\",\"name\":\"NHD Technical Team\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"caption\":\"NHD Technical Team\"},\"description\":\"NHD Technical Team maintains research-use catalog documentation and evidence summaries. Reviewed articles link to peer-reviewed papers, trial registries and regulatory records, retain null findings and study limitations, and distinguish published interventions from catalog materials. AI-assisted drafting may be used for structure; source links and evidence boundaries remain visible. This work is not independent peer review or medical advice.\",\"sameAs\":[\"https:\\\/\\\/nhdbio.com\"],\"url\":\"https:\\\/\\\/nhdbio.com\\\/fr\\\/author\\\/qianmiao-technical-team\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Cagrilintide vs CagriSema\u00a0: mol\u00e9cules, preuves d'essais et confusions courantes - NHD","description":"Une comparaison claire du cagrilintide, du s\u00e9maglutide et de la combinaison CagriSema \u00e9tudi\u00e9e, y compris les enregistrements 3 de la phase 2025 \u2013 2026 et les limites du transfert de preuves.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nhdbio.com\/fr\/cagrilintide-vs-cagrisema-evidence-boundaries\/","og_locale":"fr_FR","og_type":"article","og_title":"Cagrilintide vs CagriSema: Molecules, Trial Evidence and Common Mix-Ups","og_description":"A clean comparison of cagrilintide, semaglutide and the studied CagriSema combination, including 2025\u20132026 phase 3 records and limits on transferring evidence.","og_url":"https:\/\/nhdbio.com\/fr\/cagrilintide-vs-cagrisema-evidence-boundaries\/","og_site_name":"NHD","article_published_time":"2026-08-27T10:31:11+00:00","article_modified_time":"2026-08-28T07:31:46+00:00","og_image":[{"width":1536,"height":960,"url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/cagrilintide-vs-cagrisema-evidence-boundaries-featured-v2.webp","type":"image\/webp"}],"author":"NHD Technical Team","twitter_card":"summary_large_image","twitter_description":"Peptide Raw Materials and Custom Peptide Synthesis","twitter_misc":{"\u00c9crit par":"NHD Technical Team","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nhdbio.com\/cagrilintide-vs-cagrisema-evidence-boundaries\/#article","isPartOf":{"@id":"https:\/\/nhdbio.com\/cagrilintide-vs-cagrisema-evidence-boundaries\/"},"author":{"name":"NHD Technical Team","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1"},"headline":"Cagrilintide vs CagriSema: Molecules, Trial Evidence and Common Mix-Ups","datePublished":"2026-08-27T10:31:11+00:00","dateModified":"2026-08-28T07:31:46+00:00","mainEntityOfPage":{"@id":"https:\/\/nhdbio.com\/cagrilintide-vs-cagrisema-evidence-boundaries\/"},"wordCount":306,"commentCount":0,"publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"image":{"@id":"https:\/\/nhdbio.com\/cagrilintide-vs-cagrisema-evidence-boundaries\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/cagrilintide-vs-cagrisema-evidence-boundaries-featured-v2.webp","articleSection":["Evidence Reviews"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/nhdbio.com\/cagrilintide-vs-cagrisema-evidence-boundaries\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/nhdbio.com\/cagrilintide-vs-cagrisema-evidence-boundaries\/","url":"https:\/\/nhdbio.com\/cagrilintide-vs-cagrisema-evidence-boundaries\/","name":"Cagrilintide vs CagriSema\u00a0: mol\u00e9cules, preuves d'essais et confusions courantes - NHD","isPartOf":{"@id":"https:\/\/nhdbio.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nhdbio.com\/cagrilintide-vs-cagrisema-evidence-boundaries\/#primaryimage"},"image":{"@id":"https:\/\/nhdbio.com\/cagrilintide-vs-cagrisema-evidence-boundaries\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/cagrilintide-vs-cagrisema-evidence-boundaries-featured-v2.webp","datePublished":"2026-08-27T10:31:11+00:00","dateModified":"2026-08-28T07:31:46+00:00","description":"Une comparaison claire du cagrilintide, du s\u00e9maglutide et de la combinaison CagriSema \u00e9tudi\u00e9e, y compris les enregistrements 3 de la phase 2025 \u2013 2026 et les limites du transfert de preuves.","breadcrumb":{"@id":"https:\/\/nhdbio.com\/cagrilintide-vs-cagrisema-evidence-boundaries\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nhdbio.com\/cagrilintide-vs-cagrisema-evidence-boundaries\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/nhdbio.com\/cagrilintide-vs-cagrisema-evidence-boundaries\/#primaryimage","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/cagrilintide-vs-cagrisema-evidence-boundaries-featured-v2.webp","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/cagrilintide-vs-cagrisema-evidence-boundaries-featured-v2.webp","width":1536,"height":960,"caption":"Article-specific editorial image."},{"@type":"BreadcrumbList","@id":"https:\/\/nhdbio.com\/cagrilintide-vs-cagrisema-evidence-boundaries\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nhdbio.com\/"},{"@type":"ListItem","position":2,"name":"Cagrilintide vs CagriSema: Molecules, Trial Evidence and Common Mix-Ups"}]},{"@type":"WebSite","@id":"https:\/\/nhdbio.com\/#website","url":"https:\/\/nhdbio.com\/","name":"NHD","description":"Mati\u00e8res premi\u00e8res peptidiques et synth\u00e8se sur mesure","publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nhdbio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/nhdbio.com\/#organization","name":"NHD","url":"https:\/\/nhdbio.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","width":2172,"height":724,"caption":"NHD"},"image":{"@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1","name":"\u00c9quipe technique NHD","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","caption":"NHD Technical Team"},"description":"L'\u00e9quipe technique NHD maintient la documentation du catalogue d'utilisation de la recherche et les r\u00e9sum\u00e9s des preuves. Les articles examin\u00e9s renvoient \u00e0 des articles \u00e9valu\u00e9s par des pairs, \u00e0 des registres d'essais et \u00e0 des dossiers r\u00e9glementaires, conservent les r\u00e9sultats nuls et les limites des \u00e9tudes, et distinguent les interventions publi\u00e9es des documents du catalogue. Le dessin assist\u00e9 par AI peut \u00eatre utilis\u00e9 pour la structure\u00a0; les liens vers les sources et les limites des preuves restent visibles. Ce travail ne constitue pas un examen ind\u00e9pendant par des pairs ni un avis m\u00e9dical.","sameAs":["https:\/\/nhdbio.com"],"url":"https:\/\/nhdbio.com\/fr\/author\/qianmiao-technical-team\/"}]}},"_links":{"self":[{"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/posts\/452","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/comments?post=452"}],"version-history":[{"count":1,"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/posts\/452\/revisions"}],"predecessor-version":[{"id":519,"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/posts\/452\/revisions\/519"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/media\/622"}],"wp:attachment":[{"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/media?parent=452"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/categories?post=452"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/tags?post=452"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}